Aim: This experimental study aimed to evaluate the hepatoprotective effect on obstructive jaundice (OJ) of oral red ginseng (RG) extract, which is known to have anti-inflammatory and antioxidant properties. Methods: The rats were randomly separated into 3 groups of 10 rats: the sham group, the control group, and the treatment group. In Group 1 (sham), the common bile duct (CBD) was identified but no ligation or transection was performed. In Group 2 (control), the CBD was identified and ligation and transection were performed, but no treatment was given. In Group 3 (RG group), CBD ligation and transection were performed, then RG extract was administered via an orogastric tube at a dose of 100 mg/ kg/day for 10 days. After 10 days, blood samples were taken for biochemical analysis, and liver tissue samples for biochemical and histopathological analysis. Results: Significantly higher serum albumin levels and lower serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were determined in the RG group than in the control group (p = 0.028, p = 0.001 and p = 0.034, respectively). In the oxidative stress parameters, malondialdehyde (MDA) levels and catalase (CAT) levels were significantly different between the RG group and control group (p = <0.001 for each). Total sulfhydryl (T-SH) was not at a statistically significant level, although it was high and approached the value of the sham group ( p = 0.076). In the histopathological evaluation, the RG group had statistically significantly lower scores in all parameters compared to the control group (p<0.05). Conclusion: The results of this study showed that RG has a strong hepatoprotective effect as a result of its anti-inflammatory and antioxidant properties.
2 August 2021 in ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
Aim: It was aimed to examine the effects of Red Ginseng (RG), which has anti-inflammatory and antioxidant properties, on the histopathological alterations and lipid metabolism following splenectomy. Methods: Rats were randomly divided into 3 groups of 10 rats each. Only laparotomy was conducted in group 1 (sham). In group 2 (control), splenectomy was performed but no therapy was offered. Splenectomy was performed and RG extract was supplied orogastrically at a dosage of 100mg/kg/day for 28 days in group 3 (RG group). At the end of the 28-day period, tissue samples were obtained for the assessment of histopathological alterations in the vascular, intestinal, and lung tissues, and blood samples were obtained for biochemical analysis. Results: The RG group had reduced significantly total cholesterol (TC), triglyceride (TG), and very low density lipoprotein (VLDL) levels than the control group (p
9 December 2021 in ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
Aim: To evaluate the possible effects of red-ginseng on colon anastomosis healing in an experimental rat model. Methods: In Group 1 (sham), laparotomy and colonic mobilization were performed. Colonic transection and anastomosis were performed to Groups 2 and 3. In Group 2 (control), 2 ml of saline was administered rectally to all rats for 10 days. Group 3 (drug group) rats were given 2.5 gr/kg ml red ginseng extract rectally for 10 days. Results: The rats in the sham group had the highest bursting pressure and the rats in the red ginseng group had higher bursting pressure than in the control group (p
Introduction: Toxoplasma gondii (T. gondii) can cause serious complications in both immunocompetent and immunosuppressed individuals. This study aims to assess the seroprevalence of T. gondii among HIV-positive individuals and to investigate its association with age, sex, CD4+ T cell count, HIV RNA levels, and hematological parameters. Methods: This study included 247 HIV-positive individuals followed up at a tertiary care hospital between November 1, 2022, and November 30, 2024. We analyzed serum samples for T. gondii IgG antibodies using electrochemiluminescent microparticle immunoassay. Results: The prevalence of T. gondii IgG seropositivity was found to be 32.8% (n=81; 95% CI: 26.9-39). The median age of seropositive individuals was 52 years (IQR: 42-61), which was significantly higher compared to seronegative individuals (p<0.001). The highest IgG seropositivity rate (66.7%) was observed in the 61-80 age group. Hemoglobin levels were significantly lower in IgG seropositive individuals (p=0.040). Logistic regression analysis indicated an increased risk of T. gondii infection with advancing age. The odds ratio for the 41-60 age group was 13.3 (95% CI: 1.6-106, p=0.02), while for the 61-80 age group, it was 28 (95% CI: 3.3-240, p=0.002). Discussion: The seroprevalence of T. gondii in HIV-positive individuals was lower than both global and regional averages. Age was identified as an independent risk factor for T. gondii seropositivity. Additionally, hematological alterations associated with anemia were observed in seropositive individuals. Further large-scale, multi-center, and regionally representative studies are required to optimize T. gondii infection management and screening strategies in people living with HIV. Conclusion: These findings suggest that T. gondii infection in HIV-positive individuals increases with age and may be associated with anemia, highlighting the need for age-focused screening and management strategies.
1 January 2026 in Revista da Associação Médica Brasileira
SUMMARY OBJECTIVE: The aim of this study was to evaluate the association between oxidative stress and cervical human papillomavirus infection and cervical intraepithelial neoplasia by measuring total oxidant status, total antioxidant status, and ischemia-modified albumin levels. METHODS: In total, 50 human papillomavirus+ women, 50 cervical intraepithelial neoplasia2/3+ women, and 50 healthy women as a control group were enrolled in the prospective case–control study. The total oxidant status, total antioxidant status, and ischemia-modified albumin levels were measured with colorimetric systems. The clinical characteristics, total oxidant status, total antioxidant status, and ischemia-modified albumin levels of three groups were compared. RESULTS: The mean total antioxidant status level was higher in the control group (1.044±0.0959 mmol/L) than in the human papillomavirus+ group (0.931±0.1034 mmol/L) and the cervical intraepithelial neoplasia2/3+ group (0.927±0.0928 mmol/L) (p<0.001). The median total oxidant status level was lower in the control group than the cervical intraepithelial neoplasia2/3+ group (4.570 [4.390–4.783] μmol/L vs. 4.780 [4.443–5.035] μmol/L, p<0.05). The ischemia-modified albumin levels were similar in three groups (p=0.220). CONCLUSION: The total antioxidant status level was lower, and the total oxidant status level was higher in women with cervical intraepithelial neoplasia2/3+ compared to the control group. These findings suggest that oxidative stress is effective in the progression of human papillomavirus infection to the preinvasive lesions of the cervix. The ischemia-modified albumin was not found to be a useful biomarker to indicate oxidative stress in women with human papillomavirus infection or cervical intraepithelial neoplasia2/3 lesions.
Objective: Follicular-fluid biomarkers may characterize the peri-oocyte microenvironment, but their incremental value beyond established ovarian-reserve tests is uncertain. Methods: This prospective observational study included 42 women aged 18–40 years undergoing in vitro fertilization at Ankara Etlik City Hospital, including 21 with diminished ovarian reserve and 21 with unexplained infertility. Follicular-fluid anti-Müllerian hormone was measured by electrochemiluminescence immunoassay and leptin by enzyme-linked immunosorbent assay. Results: Pregnancy analyses used complete-case data from 22 of 25 women who underwent embryo transfer. Follicular-fluid anti-Müllerian hormone was lower in the diminished ovarian reserve group [1.13 (0.94–1.45) versus 3.40 (2.69–5.93) nanograms per milliliter; P<0.001], whereas leptin was similar (1243.73±340.50 versus 1265.78±233.35 picograms per milliliter; P=0.808). Women with diminished ovarian reserve had fewer retrieved, mature, and fertilized oocytes. Fourteen clinical pregnancies occurred among the 22 transfers with complete follow-up. Serum and follicular-fluid anti-Müllerian hormone and antral follicle count were higher among women with clinical pregnancy, but exploratory penalized regression did not identify anti-Müllerian hormone as an independent predictor. Leptin was not associated with infertility group or clinical pregnancy. Conclusion: Follicular-fluid anti-Müllerian hormone appears to reflect ovarian-reserve phenotype and granulosa-cell activity rather than provide proven incremental clinical value over serum anti-Müllerian hormone and antral follicle count. Larger follicle-matched studies with live-birth endpoints are required before either marker is used in routine clinical decision-making.